China Approves Off-Label Ivermectin Use!, 3695

Good morning, I’m still reporting on good news for Ivermectin use against COVID – if you live in China!Show more

According to a new report in yesterday’s TrialSite News, China has just passed a new law that allows for the first time by law the off label use of many drugs, including Ivermectin for COVID.

The change in Chinese laws was reported in China’s Pharma DJ and is based on the Chinese Pharmacological Society’s definition of acceptable practice for off-label drug use. The new law stipulates that:

“…when no effective treatments are available, physicians may upon patient consent, use drugs in a way that is not indicated in the package insert but is supported by medical evidence.”

According to TrialSite News, the new law merely codifies what has become acceptable practice in Chinese hospitals and among physicians for some time.

“A recent survey by the Chinese Pharmacological Society reveals that 24 hospitals, representing half of the respondents, support off-label prescribing.… hospitals recorded 1,652 off-label uses of 998 drugs, mostly indicated for oncology, immunomodulatory, cardiovascular, digestive, endocrine, and infectious disease.”

But another reason for the change is that China wanted to bring itself more in line with once-sacrosanct practices in Western medicine where clinical trials were conducted to determine the truth behind safety and efficacy of drugs for the public benefit, instead of manipulating the results for political and financial reasons.

Chinese medical authorities, are attempting to end-run these badly corrupted tenets of Western medicine, and that will make China more respected and therefore more competitive in the global market for clinical trials.

The United States is currently the world’s largest pharmaceutical market in the world

I’m still reporting from the soon-to-be-restored citadel of world freedom. Good day.